CL2009001980A1 - Combinacion farmaceutica que comprende un derivado de quinolina y uno o mas de otros agentes antimicobacterianos; composicion farmaceutica que la comprende; y uso para el tratamiento de una infeccion por una cepa de mycobacterium resistente a farmacos (divisional de la solicitud 1290-05). - Google Patents
Combinacion farmaceutica que comprende un derivado de quinolina y uno o mas de otros agentes antimicobacterianos; composicion farmaceutica que la comprende; y uso para el tratamiento de una infeccion por una cepa de mycobacterium resistente a farmacos (divisional de la solicitud 1290-05).Info
- Publication number
- CL2009001980A1 CL2009001980A1 CL2009001980A CL2009001980A CL2009001980A1 CL 2009001980 A1 CL2009001980 A1 CL 2009001980A1 CL 2009001980 A CL2009001980 A CL 2009001980A CL 2009001980 A CL2009001980 A CL 2009001980A CL 2009001980 A1 CL2009001980 A1 CL 2009001980A1
- Authority
- CL
- Chile
- Prior art keywords
- treatment
- quinoline derivative
- infection
- drug
- mycobacterium
- Prior art date
Links
- 208000015181 infectious disease Diseases 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 241000186359 Mycobacterium Species 0.000 title abstract 2
- 239000003795 chemical substances by application Substances 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 title 1
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical class N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 abstract 2
- UDPGUMQDCGORJQ-UHFFFAOYSA-N (2-chloroethyl)phosphonic acid Chemical compound OP(O)(=O)CCCl UDPGUMQDCGORJQ-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000004690 coupled electron pair approximation Methods 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
LA PRESENTE INVENCIÓN SE REFIERE A COMBINACIONES Y COMPOSICIONES FARMACÉUTICAS DE UN DERIVADO QUINOLINA SUSTITUIDO PARA LA PREPARACIÓN DE UN MEDICAMENTO PARA EL TRATAMIENTO DE UNA INFECCIÓN CON UNA CEPA DE MICOBACTERIA MULTIRRESISTENTE DONDE EL DERIVADO QUINOLINA SUSTITUIDO ES UN COMPUESTO DE ACUERDO CON LA FÓRMULA (LA) O FÓRMULA (IB) LAS SALES DE ADICIÓN DE ÁCIDO O BASE FARMACÉUTICAMENTE ACEPTABLES DEL MISMO, LAS FORMAS ESTE REOQ U ÍM ICAMENTE ISOMÉRICAS DEL MISMO, LAS FORMAS TAUTOMÉRICAS DEL MISMO O LAS FORMAS DE N-ÓXIDO DEL MISMO. ASIMISMO SE REIVINDICAN USOS DE DICHAS COMPOSICIONES Y COMBINACIONES FARMACÉUTICAS EN EL TRATAMIENTO DE INFECCIONES CON UNA CEPA DE MYCOBACTERIUM RESISTENTE A FÁRMACOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04102402 | 2004-05-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2009001980A1 true CL2009001980A1 (es) | 2010-04-16 |
Family
ID=34929150
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2009001980A CL2009001980A1 (es) | 2004-05-28 | 2009-10-20 | Combinacion farmaceutica que comprende un derivado de quinolina y uno o mas de otros agentes antimicobacterianos; composicion farmaceutica que la comprende; y uso para el tratamiento de una infeccion por una cepa de mycobacterium resistente a farmacos (divisional de la solicitud 1290-05). |
Country Status (35)
Country | Link |
---|---|
US (2) | US20070249667A1 (es) |
EP (1) | EP1753427B1 (es) |
JP (2) | JP5081617B2 (es) |
KR (2) | KR20130024969A (es) |
CN (2) | CN1976704B (es) |
AP (1) | AP2037A (es) |
AR (1) | AR049127A1 (es) |
AT (1) | ATE390925T1 (es) |
AU (1) | AU2005249231B2 (es) |
BR (1) | BRPI0510414B1 (es) |
CA (1) | CA2566544C (es) |
CL (1) | CL2009001980A1 (es) |
CY (1) | CY1110388T1 (es) |
DE (1) | DE602005005810T2 (es) |
DK (1) | DK1753427T3 (es) |
EA (1) | EA010651B1 (es) |
ES (1) | ES2306146T3 (es) |
HK (1) | HK1106136A1 (es) |
HR (1) | HRP20080307T3 (es) |
IL (1) | IL179630A (es) |
JO (1) | JO2524B1 (es) |
ME (1) | ME01105B (es) |
MX (1) | MXPA06013888A (es) |
MY (1) | MY140611A (es) |
NO (1) | NO338624B1 (es) |
NZ (1) | NZ550840A (es) |
PA (1) | PA8635201A1 (es) |
PL (1) | PL1753427T3 (es) |
PT (1) | PT1753427E (es) |
RS (1) | RS50585B (es) |
SI (1) | SI1753427T1 (es) |
TW (1) | TWI363625B (es) |
UA (1) | UA90267C2 (es) |
WO (1) | WO2005117875A1 (es) |
ZA (1) | ZA200609899B (es) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1753427T3 (da) * | 2004-05-28 | 2008-07-21 | Janssen Pharmaceutica Nv | Anvendelse af substituerede quinolinderivater til behandling af lægemiddelresistente mykobakteriesygdomme |
EA009779B1 (ru) * | 2004-12-24 | 2008-04-28 | Янссен Фармацевтика Н.В. | Лечение латентного туберкулёза |
CA2528849C (en) * | 2005-06-08 | 2014-01-14 | Janssen Pharmaceutica N.V. | Quinoline derivatives as antibacterial agents |
JP5349730B2 (ja) * | 2005-06-09 | 2013-11-20 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 抗バクテリア剤としてのキノリン誘導体 |
WO2007000434A1 (en) * | 2005-06-28 | 2007-01-04 | Janssen Pharmaceutica N.V. | Quinoline derivatives as antibacterial agents |
JO3270B1 (ar) * | 2005-06-28 | 2018-09-16 | Janssen Pharmaceutica Nv | مشتقات كوينولين بصفة عوامل مضادة للبكتيريا |
JO2752B1 (en) * | 2005-06-28 | 2014-03-15 | شركة جانسين فارماسوتيكا ان. في | Quinoline derivatives acting as antibacterial agents |
US8686002B2 (en) | 2005-08-21 | 2014-04-01 | AbbVie Deutschland GmbH & Co. KG | Heterocyclic compounds and their use as binding partners for 5-HT5 receptors |
UA97813C2 (uk) * | 2006-12-05 | 2012-03-26 | Янссен Фармацевтика Н.В. | Фумаратна сіль (альфа s, бета r)-6-бром-альфа-[2-(диметиламіно)етил]-2-метоксі-альфа-1-нафталеніл-бета-феніл-3-хінолінетанолу |
JO2685B1 (en) * | 2006-12-06 | 2013-03-03 | جانسين فارماسوتيكا ان في | Quinoline antibacterial derivatives |
JO2970B1 (en) * | 2006-12-06 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
JO2684B1 (en) * | 2006-12-06 | 2013-03-03 | جانسين فارماسوتيكا ان في | Quinoline antibacterial derivatives |
JO3271B1 (ar) * | 2006-12-06 | 2018-09-16 | Janssen Pharmaceutica Nv | مشتقات الكوينولين المضادة للجراثيم |
JO2683B1 (en) * | 2006-12-06 | 2013-03-03 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
JO2725B1 (en) * | 2006-12-06 | 2013-09-15 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
MD4009C2 (ro) * | 2008-07-15 | 2010-08-31 | Институт Химии Академии Наук Молдовы | Utilizarea 1-metil-4-(N-metilaminobutil-4)-β-carbolinei în calitate de remediu antituberculos |
RU2404971C2 (ru) * | 2008-12-02 | 2010-11-27 | ЗАО "Фарм-Синтез" | Новые производные хинолина, способ их получения, их применение для лечения микобактериальных инфекций, фармацевтическая композиция на их основе |
CA2772786A1 (en) * | 2009-09-11 | 2011-03-17 | Vertex Pharmaceuticals Incorporated | Compositions of n-benzyl-3-(4-chlorophenyl)-2-[methyl-[2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl]amino]-n-[3-(4-pyridyl)-1-[2-(4-pyridyl)ethyl]propyl]propanamide and uses thereof |
CN102249935B (zh) | 2010-05-17 | 2015-05-20 | 中国人民解放军军事医学科学院毒物药物研究所 | 芳香2-丁醇类化合物及其医药用途 |
CN104254527B (zh) | 2012-04-27 | 2017-05-31 | 詹森药业有限公司 | 抗菌的喹啉衍生物 |
AU2013254670B2 (en) | 2012-04-27 | 2017-03-30 | Janssen Pharmaceutica Nv | Antibacterial quinoline derivatives |
CN105330595B (zh) * | 2014-07-14 | 2019-12-10 | 上海嘉坦医药科技有限公司 | 吡啶衍生物及其作为抗分支杆菌的应用 |
EP3170810B1 (en) * | 2014-07-14 | 2018-09-19 | Cisen Pharmaceutical Co., Ltd. | Pyridine derivatives and anti-mycobacterial use thereof |
IL253626B1 (en) | 2015-01-27 | 2024-04-01 | Janssen Pharmaceutica Nv | dispersible preparations |
CN106279017A (zh) * | 2015-05-21 | 2017-01-04 | 重庆圣华曦药业股份有限公司 | 贝达喹啉晶型、组合物及其制备方法 |
EP3366676B1 (en) * | 2015-10-20 | 2021-05-26 | Zhejiang Hisun Pharmaceutical Co., Ltd | Crystalline forms of bedaquiline fumarate and preparation methods therefor |
WO2017121323A1 (zh) * | 2016-01-13 | 2017-07-20 | 辰欣药业股份有限公司 | 一种吡啶衍生物类化合物的制备方法及其中间体和晶型 |
CA3226824A1 (en) * | 2016-03-07 | 2017-09-14 | The Global Alliance For Tb Drug Development, Inc. | Antibacterial compounds and uses thereof |
CN107243008B (zh) * | 2017-04-13 | 2021-03-30 | 中国科学院广州生物医药与健康研究院 | 吡唑并[1,5-a]吡啶类化合物的新应用及一种治疗脓肿分枝杆菌感染的组合物 |
US11407742B2 (en) * | 2017-09-01 | 2022-08-09 | The Kitasato Institute | Compound having therapeutic activity against mycobacterium avium complex infection, and method for producing same |
WO2020047596A1 (en) * | 2018-09-04 | 2020-03-12 | Monash University | Antibacterial compounds and methods of use |
CN113271930A (zh) | 2019-01-09 | 2021-08-17 | 詹森药业有限公司 | 治疗非结核分枝杆菌疾病的组合 |
US20230348436A1 (en) * | 2019-11-26 | 2023-11-02 | Nanyang Technological University | Compounds for treating tuberculosis |
CN110804016B (zh) * | 2019-12-05 | 2022-11-04 | 福建省微生物研究所 | 抗结核分枝杆菌的二芳基喹啉衍生物 |
JP2023549605A (ja) | 2020-11-12 | 2023-11-28 | ヤンセン ファーマシューティカ エヌ.ベー. | 非結核性マイコバクテリア疾患の治療におけるベダキリン、エタンブトール、及びマクロライドの組合せ |
CN117050006A (zh) * | 2022-05-13 | 2023-11-14 | 广州嘉越医药科技有限公司 | 一种吡啶衍生物、中间体、制备方法和应用 |
CN117122595A (zh) * | 2022-05-27 | 2023-11-28 | 广州嘉越医药科技有限公司 | 吡啶衍生物的用途 |
WO2023232838A1 (en) | 2022-05-31 | 2023-12-07 | Janssen Pharmaceutica Nv | Bedaquiline for use in the treatment of leprosy |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5399558A (en) * | 1993-11-24 | 1995-03-21 | Pathogenesis Corporation | Isoflavonoid antibacterial compounds, compositions and use |
CA2270123A1 (en) * | 1996-10-28 | 1998-05-07 | Department Of The Army, U.S. Government | Compounds, compositions and methods for treating antibiotic-resistant infections |
US6103905A (en) * | 1997-06-19 | 2000-08-15 | Sepracor, Inc. | Quinoline-indole antimicrobial agents, uses and compositions related thereto |
PT2301544E (pt) * | 2002-07-25 | 2012-12-10 | Janssen Pharmaceutica Nv | Novos inibidores de micobactérias |
DK1753427T3 (da) * | 2004-05-28 | 2008-07-21 | Janssen Pharmaceutica Nv | Anvendelse af substituerede quinolinderivater til behandling af lægemiddelresistente mykobakteriesygdomme |
CA2528849C (en) * | 2005-06-08 | 2014-01-14 | Janssen Pharmaceutica N.V. | Quinoline derivatives as antibacterial agents |
-
2005
- 2005-05-24 DK DK05743054T patent/DK1753427T3/da active
- 2005-05-24 US US11/569,681 patent/US20070249667A1/en not_active Abandoned
- 2005-05-24 CA CA2566544A patent/CA2566544C/en active Active
- 2005-05-24 WO PCT/EP2005/052371 patent/WO2005117875A1/en active Application Filing
- 2005-05-24 MX MXPA06013888A patent/MXPA06013888A/es active IP Right Grant
- 2005-05-24 AU AU2005249231A patent/AU2005249231B2/en active Active
- 2005-05-24 CN CN2005800170162A patent/CN1976704B/zh active Active
- 2005-05-24 ES ES05743054T patent/ES2306146T3/es active Active
- 2005-05-24 UA UAA200611048A patent/UA90267C2/ru unknown
- 2005-05-24 CN CN2012103943126A patent/CN102908347A/zh active Pending
- 2005-05-24 KR KR1020137002606A patent/KR20130024969A/ko not_active Application Discontinuation
- 2005-05-24 AP AP2006003828A patent/AP2037A/xx active
- 2005-05-24 RS RSP-2008/0291A patent/RS50585B/sr unknown
- 2005-05-24 AT AT05743054T patent/ATE390925T1/de active
- 2005-05-24 DE DE602005005810T patent/DE602005005810T2/de active Active
- 2005-05-24 EP EP05743054A patent/EP1753427B1/en active Active
- 2005-05-24 BR BRPI0510414-9A patent/BRPI0510414B1/pt active IP Right Grant
- 2005-05-24 JO JO200574A patent/JO2524B1/en active
- 2005-05-24 NZ NZ550840A patent/NZ550840A/en unknown
- 2005-05-24 ME MEP-2008-89A patent/ME01105B/me unknown
- 2005-05-24 PL PL05743054T patent/PL1753427T3/pl unknown
- 2005-05-24 SI SI200530294T patent/SI1753427T1/sl unknown
- 2005-05-24 PT PT05743054T patent/PT1753427E/pt unknown
- 2005-05-24 KR KR1020067024974A patent/KR101371653B1/ko active Protection Beyond IP Right Term
- 2005-05-24 EA EA200602260A patent/EA010651B1/ru active Protection Beyond IP Right Term
- 2005-05-24 JP JP2007513922A patent/JP5081617B2/ja active Active
- 2005-05-27 TW TW094117334A patent/TWI363625B/zh active
- 2005-05-27 AR ARP050102200A patent/AR049127A1/es unknown
- 2005-05-27 MY MYPI20052432A patent/MY140611A/en unknown
- 2005-05-27 PA PA20058635201A patent/PA8635201A1/es unknown
-
2006
- 2006-11-27 ZA ZA200609899A patent/ZA200609899B/xx unknown
- 2006-11-27 IL IL179630A patent/IL179630A/en active IP Right Grant
- 2006-12-28 NO NO20066041A patent/NO338624B1/no unknown
-
2007
- 2007-10-23 HK HK07111416.6A patent/HK1106136A1/xx unknown
-
2008
- 2008-06-30 HR HR20080307T patent/HRP20080307T3/xx unknown
- 2008-07-02 CY CY20081100696T patent/CY1110388T1/el unknown
-
2009
- 2009-10-20 CL CL2009001980A patent/CL2009001980A1/es unknown
-
2010
- 2010-03-08 US US12/719,221 patent/US20100168133A1/en not_active Abandoned
-
2012
- 2012-07-06 JP JP2012152373A patent/JP5675718B2/ja active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2009001980A1 (es) | Combinacion farmaceutica que comprende un derivado de quinolina y uno o mas de otros agentes antimicobacterianos; composicion farmaceutica que la comprende; y uso para el tratamiento de una infeccion por una cepa de mycobacterium resistente a farmacos (divisional de la solicitud 1290-05). | |
CO2021000537A2 (es) | Inhibidores de inflamasoma nlrp3 | |
UY38425A (es) | Procesos novedosos para preparar n-((1,2,3,5,6,7-hexahidro-s-indacen-4-il)carbamoil)-1- isopropil-1h-pirazol-3-sulfonamida y sales de éste | |
AR107864A1 (es) | ÁCIDO 7a,11b-DIHIDROXI-6a-ETIL-5b-COLAN-24-OICO Y COMPOSICIONES FARMACÉUTICAS | |
UY37998A (es) | Agentes antivirales contra la hepatitis b | |
DOP2019000117A (es) | Nuevos derivados de quinolina | |
UY29384A1 (es) | Derivados del ácido2-3s,4r)-4-(((3,4-dicloro-5-metil-1h-pirrol-2-il) carbonil)amino)-1,3-tiazol-5-carboxílico y sus sales, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciónes. | |
UY37952A (es) | Formulaciones de un inhibidor de la quinasa trk macrocíclica | |
UY30759A1 (es) | Compuestos quimicos | |
UY37831A (es) | Nuevos derivados de quinolina | |
UY29410A1 (es) | Composiciones farmacéuticas en base a metilamidas del ácido 4-(4-/-3(-4-cloro-3-trifluorometifenil)ureido)fenoxi)piridin-2-carboxílico, procedimiento de preparación y aplicaciones. | |
HN2012001162A (es) | Triazolopiridinas | |
UY29562A1 (es) | Compuestos heterocíclicos de amino benzoilo, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones | |
CR20210201A (es) | Nuevos compuestos antihelmínticos | |
UY32462A (es) | Derivados de bifenilo novedosos para el tratamiento de infección por virus de hepatitis c 644 | |
CO5640037A2 (es) | Derivados de la quinazolina para el tratamiento del cancer | |
ECSP088329A (es) | Nuevos diazaespiroalcanos y su uso para el tratamiento de enfermedades mediadas por ccr8 | |
ECSP066990A (es) | Formulaciones con liberación controlada de principio activo que contienen vardenafilo | |
UY29648A1 (es) | Derivados de piridopirimidina, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones | |
UY30544A1 (es) | Compuestos de pirrolo-piperidina y sales farmacéuticametne aceptables de los mismos, procesos de fabricacion, composiciones y aplicaciones | |
CO2019011877A2 (es) | Nuevos derivados de pirazol bicíclicos | |
CL2020002891A1 (es) | Nuevos derivados de quinolina | |
NI201900063A (es) | Amidas aromáticas de ácido carboxílico | |
BR112015005347A2 (pt) | composto, composição farmacêutica, e, método para tratamento ou profilaxia de infecção por hiv ou para tratamento, profilaxia, ou atraso no início de aids | |
UY30847A1 (es) | Uso de derivados de mononitrato de dianhidrohexita como agentes para el tratamiento de trastornos intestinales |